Surgical Science Sweden AB (publ)

Good day and welcome to another Rapport Commentary. This time it's Surgical Science that has closed their books for the first quarter of 2022. And with me on the link to comment on the quarter, I have Gisli Hennemark, VD. Welcome! Thank you so much, Mike. It's great to be here. It's great to have you back. We'll start with the figures first. The net turnover reached 159 million, a fairly substantial increase compared to the previous year's first quarter of 37 million kronor. The turnover result reached 20 million kronor, an increase also from the previous year's first quarter. What do you think of these figures?

Well, it's a good start to 2022. And then, of course, in terms of bookkeeping, it will be a very big increase. But if you look at comparable units, as if we had owned the companies we acquired during the whole period of 2021, then it is still an increase of over 30 percent in turnover. And then it is mainly educational products where we sell product to the university hospital under our own brand, which has gone very strong in the quarter, made 60% of the turnover. For some reason, there is a currency effect there. We have definitely been helped by the weaker crown. It is about half of that growth if you look at so-called currency-adjusted growth. But we're happy with it. We're happy with the start.

Educational Products has grown. What's behind that growth?